1. Home
  2. OFLX vs QTTB Comparison

OFLX vs QTTB Comparison

Compare OFLX & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omega Flex Inc.

OFLX

Omega Flex Inc.

HOLD

Current Price

$25.96

Market Cap

266.9M

Sector

Industrials

ML Signal

HOLD

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

SELL

Current Price

$8.94

Market Cap

265.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
OFLX
QTTB
Founded
1975
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
266.9M
265.2M
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
OFLX
QTTB
Price
$25.96
$8.94
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $39.67
AVG Volume (30 Days)
39.0K
★ 519.2K
Earning Date
10-28-2026
11-04-2026
Dividend Yield
★ 5.13%
N/A
EPS Growth
N/A
★ 136.78
EPS
★ 0.70
N/A
Revenue
★ $98,296,000.00
$53,737,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$150.00
P/E Ratio
$37.74
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$23.99
$1.91
52 Week High
$37.92
$23.57

Technical Indicators

Market Signals
Indicator
OFLX
QTTB
Relative Strength Index (RSI) 56.04 46.44
Support Level $24.67 $7.45
Resistance Level $26.97 $9.16
Average True Range (ATR) 0.95 0.50
MACD 0.23 0.21
Stochastic Oscillator 67.29 71.54

Price Performance

Historical Comparison
OFLX
QTTB

About OFLX Omega Flex Inc.

Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

Share on Social Networks: